Literature DB >> 1348768

Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime.

A P Johnson1, M J Weinbren, B Ayling-Smith, S K Du Bois, S G Amyes, R C George.   

Abstract

During an 8-month period, Klebsiella pneumoniae resistant to cefotaxime and ceftazidime were isolated from 18 elderly patients in two closely-situated UK hospitals. Amongst these 18 patients, the organisms were isolated from urine samples of 17, from blood cultures of two and from a wound swab of one. The infected patients were located in nine different wards and several of the patients had been transferred between wards, within and between the two hospitals. All the bacterial isolates belonged to serotype K62, were non-typable or reacted only weakly with bacteriophage, showed similar plasmid profiles and were resistant to tetracycline and trimethoprim, thus indicating they were the same strain. Resistance to cefotaxime and ceftazidime was inhibited by clavulanic acid suggesting the involvement of extended-spectrum beta-lactamase (ESBL) enzyme activity. This was confirmed by analytical isoelectric focusing, which showed that isolates each produced two beta-lactamases with isoelectric points of 7.0(SHV-3) and 7.6 (SHV-1/2) respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348768     DOI: 10.1016/0195-6701(92)90111-x

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.

Authors:  K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; B Cookson; G French
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 2.  Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae.

Authors:  H Sahly; R Podschun
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae.

Authors:  A Gori; F Espinasse; A Deplano; C Nonhoff; M H Nicolas; M J Struelens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

Authors:  G L French; K P Shannon; N Simmons
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Generation and Validation of the iKp1289 Metabolic Model for Klebsiella pneumoniae KPPR1.

Authors:  Christopher S Henry; Ella Rotman; Wyndham W Lathem; Keith E J Tyo; Alan R Hauser; Mark J Mandel
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 6.  Surveillance of antibiotic resistance.

Authors:  Alan P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

7.  Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan.

Authors:  P Y Liu; J C Tung; S C Ke; S L Chen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Rapid detection of Klebsiella pneumoniae from blood culture bottles by real-time PCR.

Authors:  Prathiba Kurupati; Carol Chow; Gamini Kumarasinghe; Chit Laa Poh
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

Authors:  G Arlet; M Rouveau; I Casin; P J Bouvet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

Review 10.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.